Burden of Illness and Treatment Assessment of Patients With Dry Eye Disease: A Cross-Sectional Survey of Real-World Patients With Dry Eye Disease in the US

Novartis Pharmaceuticals946 enrolled

Overview

This study employed secondary database analysis of the Adelphi Dry Eye Disease (DED) Disease Specific Programme™ (DSP™), a templatized cross-sectional survey with retrospective data collection that is administered by Adelphi to a convenience sample of patients diagnosed with DED, and their consulting physicians in the United States. In addition to the survey data, the DED DSP also included recorded medical history data as reported by physicians (optometrists, ophthalmologists or refractive surgeons).

Study Type

OBSERVATIONAL

Enrollment

946

Conditions

Dry Eye Disease

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: Main Sample: * ≥ 18 years of age. * Physician-confirmed DED diagnosis (at time of data collection). Xiidra® Oversample: * ≥ 18 years of age. * Physician-confirmed DED diagnosis (at time of data collection). * Have a current prescription for Xiidra® for their DED (at time of data collection). Exclusion Criteria: Main Sample: • Involved in a DED clinical trial (at time of data collection). Xiidra® Oversample: * Involved in a DED clinical trial (at time of data collection). * Included in the main sample previously.

Locations (1)

Novartis

East Hanover, New Jersey, United States

Outcomes

Primary Outcomes

Impact of Dry Eye on Everyday Life questionnaire© (IDEEL) mean scores

Mean IDEEL score on Symptom Bother dimension: score range 0-100, where higher scores indicate greater bother. Mean IDEEL scores on Daily Activities, Emotional Impact, and Work dimensions: score range 0-100, where higher scores indicate lesser impact.